Cargando...
Addressing COVID‐19 Drug Development with Artificial Intelligence
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the virus that led to the COVID‐19 (Coronavirus Disease 2019) pandemic, has resulted in substantial overburdening of healthcare systems as well as an economic crisis on a global scale. This has in turn resulted in widespr...
Guardado en:
| Publicado en: | Adv Intell Syst |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7235485/ https://ncbi.nlm.nih.gov/pubmed/32838299 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/aisy.202000070 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|